{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T07:35:28Z","timestamp":1782027328170,"version":"3.54.5"},"reference-count":39,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T00:00:00Z","timestamp":1566777600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100013120","name":"European Medicines Agency","doi-asserted-by":"publisher","award":["EMA\/2015\/25\/PH"],"award-info":[{"award-number":["EMA\/2015\/25\/PH"]}],"id":[{"id":"10.13039\/501100013120","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacoepidemiology and Drug"],"published-print":{"date-parts":[[2019,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objectives<\/jats:title><jats:p>In November 2014, the CMDh (a regulatory body representing EU Member States) advised doctors not to prescribe sodium valproate for epilepsy or bipolar disorder in preg nant women, in women who can become pregnant, or in girls unless other treatments are ineffective or not tolerated. This study aimed to determine if this warning led to changes in prescription patterns.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design and setting<\/jats:title><jats:p>Cohort of 5.4 million women aged between 10 and 50 years identified in electronic health care data from United Kingdom, France, and Italy (2007\u20132016).<\/jats:p><\/jats:sec><jats:sec><jats:title>Main outcome measures<\/jats:title><jats:p>Anti\u2010epileptic drug (AED) prescriptions.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The prevalence of women receiving AED prescriptions in 2016 varied from 12.2 per 1000 to 29 per 1000 in the four regions. The incidence of prescribing any AED (excluding clonazepam, gabapentin, and pregabalin) fell each year on average by 7.5% (95% CI, 7.0%\u20108.0%; Emilia Romagna), 9.6% (8.3%\u201011.0%; France), 7.1% (6.7%\u20107.6%; Tuscany), and 0.4% (0.2%\u20101.0%; United Kingdom). The relative odds of prescribing sodium valproate rather than any other AED decreased more after 2014 compared with before the end of 2014 in France (OR = 0.77; 95% CI, 0.60\u20100.98), Tuscany (0.81; 0.76\u20100.86), Emilia Romagna (0.83; 0.76\u20100.90), and the United Kingdom (0.92; 0.80\u20101.06; not statistically significant).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>There is evidence that the CMDh warning did lead to changes in prescription patterns of sodium valproate in women of childbearing age. There were considerable differences in prescribing practice amongst regions of Europe.<\/jats:p><\/jats:sec>","DOI":"10.1002\/pds.4881","type":"journal-article","created":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T03:38:49Z","timestamp":1566877129000},"page":"1519-1528","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Did advice on the prescription of sodium valproate reduce prescriptions to women? An observational study in three European countries between 2007 and 2016"],"prefix":"10.1002","volume":"28","author":[{"given":"Rachel","family":"Charlton","sequence":"first","affiliation":[{"name":"Department of Pharmacy and Pharmacology University of Bath  Bath UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Damase\u2010Michel","sequence":"additional","affiliation":[{"name":"Pharmacologie Facult\u00e9 de M\u00e9decine Universit\u00e9 Toulouse III, CHU Toulouse, INSERM UMR1027  France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7651-9130","authenticated-orcid":false,"given":"Caroline","family":"Hurault\u2010Delarue","sequence":"additional","affiliation":[{"name":"Pharmacologie Facult\u00e9 de M\u00e9decine Universit\u00e9 Toulouse III, CHU Toulouse, INSERM UMR1027  France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Gini","sequence":"additional","affiliation":[{"name":"Agenzia regionale di sanit\u00e0 della Toscana  Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Loane","sequence":"additional","affiliation":[{"name":"Institute of Nursing and Health Research Ulster University  Co Antrim Northern Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Pierini","sequence":"additional","affiliation":[{"name":"Institute of Clinical Physiology \u2010 National Research Council (IFC\u2010CNR)\/Fondazione Toscana \u201cGabriele Monasterio\u201d  Pisa Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurora","family":"Puccini","sequence":"additional","affiliation":[{"name":"Drug Policy Service Emilia Romagna Region Health Authority  Bologna Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Neville","sequence":"additional","affiliation":[{"name":"IMER (Emilia Romagna Registry of Birth Defects), Centre for Clinical and Epidemiological Research University of Ferrara and Azienda Ospedaliero\u2010Universitaria di Ferrara  Ferrara Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Snowball","sequence":"additional","affiliation":[{"name":"Department of Pharmacy and Pharmacology University of Bath  Bath UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7164-612X","authenticated-orcid":false,"given":"Joan K.","family":"Morris","sequence":"additional","affiliation":[{"name":"Centre for Environmental and Preventive Medicine Queen Mary University of London  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the EUROmediSAFE consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,8,26]]},"reference":[{"key":"e_1_2_13_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2009.07.005"},{"issue":"10","key":"e_1_2_13_3_1","first-page":"939","article-title":"Antiepileptic use for epilepsy and nonepilepsy disorders","volume":"86","author":"Leong C","year":"2016","journal-title":"A population\u2010based study (1998\u20132013)"},{"key":"e_1_2_13_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2007.01970.x"},{"key":"e_1_2_13_5_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0028725"},{"key":"e_1_2_13_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.2006.00639.x"},{"key":"e_1_2_13_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2009.03.002"},{"key":"e_1_2_13_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1871"},{"key":"e_1_2_13_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2011.02.012"},{"key":"e_1_2_13_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/epi.12557"},{"key":"e_1_2_13_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.3847"},{"key":"e_1_2_13_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1479-828X.2011.01359.x"},{"key":"e_1_2_13_13_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0052339"},{"key":"e_1_2_13_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/ppe.12004"},{"key":"e_1_2_13_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2008.04.022"},{"key":"e_1_2_13_16_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2005.074203"},{"key":"e_1_2_13_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/epi.13632"},{"key":"e_1_2_13_18_1","first-page":"Cd010224","article-title":"Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child","volume":"11","author":"Weston J","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"e_1_2_13_19_1","first-page":"Cd010236","article-title":"Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child","author":"Bromley R","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_13_20_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000339399.64213.1a"},{"issue":"7","key":"e_1_2_13_21_1","first-page":"643","article-title":"Neurodevelopment of children exposed in utero to lamotrigine, sodium valproate and carbamazepine. Archives of Disease in Childhood. 2011;96(7):643\u20107","volume":"96","author":"Cummings C","journal-title":"PubMed PMID"},{"key":"e_1_2_13_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2009.04.026"},{"key":"e_1_2_13_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2007.01376.x"},{"key":"e_1_2_13_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(12)70323-X"},{"key":"e_1_2_13_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.3613"},{"key":"e_1_2_13_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.3984"},{"issue":"1","key":"e_1_2_13_27_1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.31887\/DCNS.2008.10.1\/hcrgrunze","article-title":"The effectiveness of anticonvulsants in psychiatric disorders","volume":"10","author":"Grunze HCR","year":"2008","journal-title":"Dialogues Clin Neurosci"},{"key":"e_1_2_13_28_1","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/520784"},{"key":"e_1_2_13_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.12791"},{"key":"e_1_2_13_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-016-2092-3"},{"key":"e_1_2_13_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12577"},{"key":"e_1_2_13_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/bdra.23147"},{"key":"e_1_2_13_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2009.02093.x"},{"key":"e_1_2_13_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2016.01.019"},{"key":"e_1_2_13_35_1","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2008.144386"},{"key":"e_1_2_13_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13892"},{"key":"e_1_2_13_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-015-0303-6"},{"key":"e_1_2_13_38_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002767"},{"key":"e_1_2_13_39_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000003959"},{"key":"e_1_2_13_40_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40801-016-0078-1"}],"container-title":["Pharmacoepidemiology and Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pds.4881","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/pds.4881","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pds.4881","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T10:44:47Z","timestamp":1694169887000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pds.4881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,26]]},"references-count":39,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["10.1002\/pds.4881"],"URL":"https:\/\/doi.org\/10.1002\/pds.4881","archive":["Portico"],"relation":{},"ISSN":["1053-8569","1099-1557"],"issn-type":[{"value":"1053-8569","type":"print"},{"value":"1099-1557","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,26]]},"assertion":[{"value":"2018-10-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-07-22","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-08-26","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}